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Arboviral diseases (dengue, chikungunya, zika, and yellow fever) are emerging as a major threat worldwide. Chikungunya derives its name from the Makonde term 
kungunyala, meaning “that which bends up” [1]. It has resurfaced 
in India over the past 10 years (2005–2006) [1]. Resurgence of 
chikungunya has been attributed to the various factors including 
urbanization, absence of herd immunity, and mutation in the 
E1 gene causing a significant upsurge in chikungunya virus 
infectivity. As per the annual report (2016–2017) of the Ministry 
of Health and Family Welfare, 49,659 cases of chikungunya were 
reported across India, with national capital reporting as many as 
11,915 cases until November 2016. There are a limited number 
of studies among children with chikungunya and associated 
coinfections from India [2,3]. We conducted a retrospective 
analysis among a cohort of chikungunya-positive hospitalized 
children to elicit the clinicodemographic profile of chikungunya 
and to understand the impact of coinfections.
MATERIALS AND METHODS
After getting approval from the Institutional Ethical Committee, 
we conducted this single-centered retrospective analytical 
study in the Department of Pediatrics from July 1, 2016, to 
November 30, 2016. The patient identification details such as 
name, age, sex, and central record number of all children (1 month 
to 14 years) with immunoglobulin M-positive chikungunya 
serology by MAC-ELISA kit (developed by National Institute 
of Virology, Pune, India) were collected from the microbiology 
laboratory record book.
Through proper channel, patient particular matched case 
sheets of shortlisted patients were released from Medical Record 
Section (Fig. 1). Patients with incomplete case record sheets and 
those leaving against medical advice were excluded.
Pre-designed case record forms were used to enter 
baseline data such as age, sex, residence, month of admission, 
presenting symptoms and its duration, details of examination, 
laboratory parameters at admission (hematocrit, total leukocyte 
count [TLC], differential leukocyte count, platelet count 
at admission, and the lowest platelet count; liver function 
parameters such as serum bilirubin, aspartate transaminase 
[AST], and alanine transaminase [ALT]), and radiological 
parameters [chest X-ray and ultrasound findings]). The details of 
any coinfection mentioned in the case record were also noted. The 
cutoffs for various clinical and laboratory parameters were taken 
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as per standard age-dependent references in children. Details of 
treatment (duration of intravenous fluids, vasopressors, and blood 
component therapy), condition at discharge, and mortality were 
noted. All children were categorized into either Group A (isolated 
chikungunya infection) or Group B (coinfection). Groups A and 
B were compared to see any statistically significant difference in 
the clinical and laboratory parameters.
The data collected in a predesigned pro forma were entered 
into MS Excel 2007 and analyzed using software Stat 12.0. 
Mean±standard deviation and median (p25–p75) were calculated 
for the quantitative variables following normal distribution and 
non-normal distribution, respectively, while all qualitative variables 
were expressed in number (%). All quantitative variables were 
compared between two group using t-test if underlying distribution 
was normal otherwise counterpart of t-test, i.e., rank-sum test was 
used. Chi-square test/Fisher exact test was used to see an association 
between all qualitative variables with our grouping variable. The 
significance level was considered at p=0.05.
RESULTS
Of 102 children, 44.1% (45) of children had isolated chikungunya 
infection, 36.3% (37) had dengue coinfection, and 19.6% (20) 
had other coinfections with chikungunya. After dengue, the most 
common coinfection was enteric fever (6.8%, 7), followed by 
malaria in 5.9% of cases (Plasmodium vivax - 5 and P. vivax+ 
Plasmodium falciparum - 1), pyomeningitis in 4.9% (5) of cases, 
and viral hepatitis A in 2% of cases. The age- and month-wise 
distributions of cases are depicted in Fig. 2. Of 102 children, 
62.7% (64) were boys and 37.3% (38) were girls. 90.1% (92) 
were residents from Delhi and NCR, while 9.8% (10) were from 
the neighboring states of Delhi (Uttar Pradesh, Haryana, and 
Rajasthan).
Clinical presentation, physical examination findings, 
and laboratory parameters in both groups were comparable 
(Table 1) except for the vomiting and splenomegaly, which were 
significantly more in the coinfection group (p<0.05).
The morbidity profile in both the groups was comparable 
except that the highest axillary temperature recorded was 
significantly higher in coinfection group than in the isolated 
chikungunya group (101.84±1.99°F vs. 100.93±1.91°F; 
p=0.04) and the duration of intravenous antibiotics was 
significantly higher in the coinfection group (Table 2). There 
was only one death in the coinfection group due to dengue 
shock syndrome.
Figure 1: Flow chart of study participants
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DISCUSSION
Chikungunya is an epidemic vector-borne arboviral disease. 
The first case in India was reported in 1963 from West Bengal 
followed by several outbreaks in southern, western, and eastern 
India between 1964 and 1973 [1-3]. This single-center study 
from Delhi retrospectively analyzed chikungunya outbreak 
among children in the national capital during 2016 and the 
impact of coinfections during the same period. During the period 
from July to November, i.e., monsoon and post-monsoon season, 
47.6% (102/214) of the seropositive chikungunya children were 
hospitalized. The most common age group in our study was 
4–10 years of age with maximum cases seen in October. This was 
in concordance with a study from another tertiary care hospital 
of Delhi where the post-monsoon month of November was 
reported as the peak month unlike summer months as reported 
from South India. However, the earlier studies conducted in the 
national capital on patients of chikungunya have included all age 
Table 1: Comparative analysis of clinical and laboratory profile of isolated chikungunya (Group A) and coinfection (Group B)
Variables Isolated chikungunya n=45 (%) Coinfection n=57 (%) p value
Clinical presentation
Fever 43 (95.55) 56 (98.25) 0.42
Vomiting 21 (46.67) 38 (66.67) 0.04
Abdominal pain 17 (37.78) 23 (40.35) 0.76
Poor oral intake 18 (40.00) 17 (29.82) 0.24
Headache 14 (31.11) 18 (31.58) 0.91
Rash 15 (33.33) 11 (19.30) 0.09
Generalized body ache 7 (15.55) 14 (24.56) 0.38
Seizures 8 (17.78) 8 (14.04) 0.60
Altered sensorium 5 (11.11) 9 (15.79) 0.49
Backache 5 (11.11) 9 (15.79) 0.49
Cough 6 (13.33) 8 (14.04) 0.95
Joint pain 6 (13.33) 7 (12.28) 0.84
Loose stools 3 (6.67) 9 (15.79 0.15
Irritability 4 (8.89) 6 (10.53) 0.78
Dizziness 2 (4.44) 5 (8.77) 0.39
Jaundice 4 (8.89) 1 (1.75) 0.09
Physical examination
Hepatomegaly 18 (40.00) 32 (56.14) 0.08
Muscle tenderness 16 (35.55) 27 (47.36) 0.81
Abdominal tenderness 4 (8.89) 14 (24.56) 0.67
Splenomegaly 3 (6.67) 14 (24.56) 0.01
Arthritis 3 (6.67) 3 (5.26) 0.41
Petechiae 0 (0.00) 4 (7.02) 0.06
Laboratory values 
TLC (cell/mm3) 8000 (4300–12000) 7000 (5600–9500) 0.85
Hematocrit (%) 30.50±10.07 30.49±7.05 0.49
Platelet count (cells/mm3) 1.6 (1–2.5) 1.2 (0.5–1.2) 0.09
SGOT (IU/L) 51 (37–119) 78 (45–125) 0.19
SGPT (IU/L) 33 (23–62) 49 (25–80) 0.31
Data expressed as number (%), §Age expressed as mean±SD, and Lab values expressed as Median (p25–p75). SD: Standard deviation, SGPT: Serum glutamate pyruvate 
transaminase, SGOT: Serum glutamic oxaloacetic transaminase, TLC: Total leukocyte count
Figure 2: Distribution of a number of patients in different age groups 
admitted in various months of study period
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groups as opposed to the exclusivity of pediatric patients in our 
study [4,5].
Of 102 cases with chikungunya infection, 56% (57/102) 
had evidence of coinfections and dengue was the most common 
coinfection seen in 36.2% (37) of cases. The prevalence of 
coinfection with dengue using serological tests has been previously 
reported to be 2.7–12.4% [6,7]. Artificial collection of water in 
June–September rains and Aedes being the common vector may be 
the possible explanation for the high incidence of this coinfection.
The most common symptoms were fever, vomiting, poor oral 
intake, and abdominal pain across both the groups. The classic 
triad of fever, rash, and joint pains was present in only 3/45 cases 
of isolated chikungunya infection. This was in contrast to most 
of the studies done earlier. The study done in children during the 
Caribbean epidemic showed that the predominant complaints in 
confirmed cases of chikungunya were joint pains (98.6%) and skin 
rash (46.4%) [8]. Similarly, severe arthralgia and joint swelling 
were the dominant features in chikungunya in another study 
from West Bengal, and abdominal pain was dominant in cases 
of dengue. Diarrhea was seen only in cases of dual infection [7].
Sahadeo et al. had shown that a combination of joint pain, 
rash, and TLC <7000/mm3 was able to differentiate chikungunya 
from other acute undifferentiated febrile illnesses [9]. Our study 
highlighted the fact that, apart from the common mosquito-borne 
coinfections such as malaria and dengue, non-mosquito-borne 
endemic infections such as enteric fever, pyomeningitis, and viral 
hepatitis may also coexist with chikungunya infection. This may 
explain the significantly higher preponderance of vomiting and 
splenomegaly in the coinfection group (p<0.05). Hepatomegaly, 
muscle tenderness, and abdominal tenderness were also more 
common though not statistically significant.
Rash is a predominant feature of arboviral infections; however, 
it was found only in 25% (26/102) of the patients in our study. 
It was maculopapular in 58% (15/26), flushing in 27% (6/26), 
vesiculobullous in 15.4% (4/26), and hyperpigmented rash in 
3.8% (1/26) of cases. In most of the patients, it was a generalized 
type of rash seen in 42% (11/26) of cases. In a previous study 
from South India on 52 children, the pigmented rash was the most 
common (27/52) type, followed by vesicobullous rash (16/52) 
and maculopapular rash (14/52) [10].
Only 13 (12.7%) children presented with joint pains, of 
which six were in the isolated chikungunya group and seven in 
the coinfections group. Restriction of movement was noted in 
9/13 (69.2%) patients and knee joint being the most common joint 
involved. However, any joint can be involved in chikungunya, but 
most commonly reported joints are the wrist, metacarpophalangeal, 
interphalangeal, ankle, and metatarsophalangeal joints [11]. This 
above phenomenon might highlight a changing pattern of infectivity 
of the virus and the fact that clinicians must be adept enough to 
suspect chikungunya infection in children, during the mosquito-
breeding season, even without the classical presenting features.
Among the alarming laboratory parameters, leukopenia, 
because of lymphopenia, has been most commonly been reported. 
There have been reports of increased transaminases, raised 
hematocrit, and occasionally thrombocytopenia in chikungunya. 
The mean platelet count was lower in the coinfection group 
(1.2 vs. 1.6 lakhs), whereas the mean AST/ALT was found to be 
higher in the coinfection group [12,13].
Complications such as fluid leak, shock, and bleeding were 
present in both the groups. However, their presence in the isolated 
chikungunya group reflects that chikungunya which is generally a 
benign disease can be potentially fatal as well. In concordance with our 
data, a retrospective pediatric intensive care unit study of nine children 
with chikungunya showed the presence of extensive skin blisters 
in 5 children, encephalopathy in 4, myocarditis and hemodynamic 
disorders in 5, and bleeding in 1 [14]. Strength of our study was 
exclusive pediatric study during a large outbreak of chikungunya in 
a tertiary care hospital of North India. However, limitations were that 
only indoor patients were enrolled and outpatients were excluded. 
There were no long-term follow-up of cases. The data from these 
patients could have given us additional valuable insight into milder 
presentations of chikungunya and any significant long-term morbidity.
CONCLUSION
Typical presentation of fever, rash, and joint pains is rare among 
children with chikungunya. A high index of suspicion in monsoon 
and post-monsoon season is necessary due to the potential risk 
Table 2: Morbidity profile
Variable Isolated chikungunya (n=45) Coinfection (n=57) p-value
Maximum axillary temperature (°F)§ 100.93±1.91 101.84±1.99 0.04
Duration of IV fluids (days) 6 (0–10) 7 (5–15) 0.3710
Duration of IV antibiotics (days) 5 (5–15) 6 (0–10) 0.06
Duration of hospital stay (days) 8 (5–15) 7 (4–11) 0.2331
Lowest platelets (in lakhs) (cells/mm3) 1.50 (0.60–2.30) 1.00 (0.40–2.00) 0.1076
Total duration of fever (days)§ 8.05±6.64 9.78±9.06 0.323
Shockα (%) 11 (24.44) 18 (31.58) 0.428
Fluid leakα (%) 3 (6.67) 10 (17.54) 0.614
Bleedingα (%)
Epistaxis 2 (4.44) 3 (5.26) 0.818
Gum bleed 1 (2.22) 3 (5.26) 0.458
Values are expressed as §mean±SD, αnumber (%) and median (p25–p75). SD: Standard deviation
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of complications such as bleeding and shock. High-rise of 
temperature, presence of vomiting, and splenomegaly can be the 
clues to investigate other coinfections.
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